Tuesday, September 7, 2010
The Summit
25th - 27th October 2010
Summit Venue
The Fairmont Turnberry Isle Resort & Club, Miami
The Next Generation Pharmaceutical Summit has grown to become the standard for senior level pharmaceutical executives looking to share ideas with peers, build partnerships with industry thought leaders, and hear from key experts on how to address some of their most pressing challenges in discovery and development, clinical research and beyond.
Past and Present VIP Attendees
Diane Jorkasky
VP of Global Clinical Research Operations
Pfizer Inc.
VP of Global Clinical Research Operations
Pfizer Inc.
Francesco M. Marincola
Chief Infectious Disease
NIH
Chief Infectious Disease
NIH
Jean-Pierre Bizzari
VP of Clinical Development, Oncology
sanofi-aventis
VP of Clinical Development, Oncology
sanofi-aventis
Christian Jacques
VP Clinical Development
Celgene
VP Clinical Development
Celgene
Coreen Oei
VP Clinical Sciences & Study Operations
GSK
VP Clinical Sciences & Study Operations
GSK
Kirk Shepard
SVP Medical & Scientific Affairs
Takeda Pharmaceuticals
SVP Medical & Scientific Affairs
Takeda Pharmaceuticals
John Smith
VP Clinical Research
Boehringer Ingelheim Pharmaceuticals, Inc.
VP Clinical Research
Boehringer Ingelheim Pharmaceuticals, Inc.
Francis Cuss
SVP Discovery and Exploratory Clinical Research
Bristol Myers-Squibb
SVP Discovery and Exploratory Clinical Research
Bristol Myers-Squibb
Amrit Ray
VP Global Pharmacovigilance & Epidemiology – Medical Safety
Bristol-Myers Squibb
VP Global Pharmacovigilance & Epidemiology – Medical Safety
Bristol-Myers Squibb
Oscar Laskin
VP Early Drug Development
Celgene
VP Early Drug Development
Celgene
Anne Phillips
VP of Discovery Medicine
GSK
VP of Discovery Medicine
GSK
Stephen Eck
VP Translational Medicine & Pharmacogenomics
Eli Lilly
VP Translational Medicine & Pharmacogenomics
Eli Lilly
Haren Rupani
Global Head Oncology Clinical Imaging
Novartis
Global Head Oncology Clinical Imaging
Novartis
Robert Spiegel
Chief Medical Officer and SVP
Schering-Plough Corporation
Chief Medical Officer and SVP
Schering-Plough Corporation
Ismail Kola
SVP Discovery Research and Chief Scientific Officer
Schering-Plough Corporation
SVP Discovery Research and Chief Scientific Officer
Schering-Plough Corporation
Thorir D. Bjornsson
VP Early Development and Clinical Pharmacology
Wyeth
VP Early Development and Clinical Pharmacology
Wyeth
Giora Z. Feuerstein
Assistant VP Translational Medicine
Wyeth
Assistant VP Translational Medicine
Wyeth
Kenneth Kaitin
Director
Tufts Center for the Study of Drug Development
Director
Tufts Center for the Study of Drug Development
Dr. Thomas Haverty
Group Vice President of Global Clinical Research
Schering-Plough Corporation
Group Vice President of Global Clinical Research
Schering-Plough Corporation
Dr. David Spencer
COO and SVP of Research and Development
Biolex
COO and SVP of Research and Development
Biolex
Diane Jorkasky
VP of Global Clinical Research Operations
Pfizer Inc.
VP of Global Clinical Research Operations
Pfizer Inc.
Francesco M. Marincola
Chief Infectious Disease
NIH
Chief Infectious Disease
NIH
Jean-Pierre Bizzari
VP of Clinical Development, Oncology
sanofi-aventis
VP of Clinical Development, Oncology
sanofi-aventis
Christian Jacques
VP Clinical Development
Celgene
VP Clinical Development
Celgene
Coreen Oei
VP Clinical Sciences & Study Operations
GSK
VP Clinical Sciences & Study Operations
GSK
Kirk Shepard
SVP Medical & Scientific Affairs
Takeda Pharmaceuticals
SVP Medical & Scientific Affairs
Takeda Pharmaceuticals
John Smith
VP Clinical Research
Boehringer Ingelheim Pharmaceuticals, Inc.
VP Clinical Research
Boehringer Ingelheim Pharmaceuticals, Inc.
Francis Cuss
SVP Discovery and Exploratory Clinical Research
Bristol Myers-Squibb
SVP Discovery and Exploratory Clinical Research
Bristol Myers-Squibb
Amrit Ray
VP Global Pharmacovigilance & Epidemiology – Medical Safety
Bristol-Myers Squibb
VP Global Pharmacovigilance & Epidemiology – Medical Safety
Bristol-Myers Squibb
Oscar Laskin
VP Early Drug Development
Celgene
VP Early Drug Development
Celgene
Anne Phillips
VP of Discovery Medicine
GSK
VP of Discovery Medicine
GSK
Stephen Eck
VP Translational Medicine & Pharmacogenomics
Eli Lilly
VP Translational Medicine & Pharmacogenomics
Eli Lilly
Haren Rupani
Global Head Oncology Clinical Imaging
Novartis
Global Head Oncology Clinical Imaging
Novartis
Robert Spiegel
Chief Medical Officer and SVP
Schering-Plough Corporation
Chief Medical Officer and SVP
Schering-Plough Corporation
Ismail Kola
SVP Discovery Research and Chief Scientific Officer
Schering-Plough Corporation
SVP Discovery Research and Chief Scientific Officer
Schering-Plough Corporation
Thorir D. Bjornsson
VP Early Development and Clinical Pharmacology
Wyeth
VP Early Development and Clinical Pharmacology
Wyeth
Giora Z. Feuerstein
Assistant VP Translational Medicine
Wyeth
Assistant VP Translational Medicine
Wyeth
Kenneth Kaitin
Director
Tufts Center for the Study of Drug Development
Director
Tufts Center for the Study of Drug Development
Dr. Thomas Haverty
Group Vice President of Global Clinical Research
Schering-Plough Corporation
Group Vice President of Global Clinical Research
Schering-Plough Corporation
Dr. David Spencer
COO and SVP of Research and Development
Biolex
COO and SVP of Research and Development
Biolex
Summit Update
Get the latest summit news sent to your email or mobile.
Keynote Address
Keynote Address by Thomas Haverty, Global VP, Schering-Plough
Source: www.ngpsummit.com© 2010 GDS International Ltd. All rights reserved.